Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Income from Continuing Operations came in at 57000.0 in Q4 2025, up 101.8% year-on-year from 28245.66 in Q4 2024, and down 95.64% on a QoQ basis from 1308000.0 in Q3 2025.
Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Income from Continuing Operations data on file, last reported at 57000.0 in Q4 2025.
- On a quarterly basis, Income from Continuing Operations rose 101.8% year-over-year to 57000.0 in Q4 2025; TTM through Dec 2025 was 4973000.0, a 130.23% increase from a year earlier, with the FY2025 full-year figure at 4973000.0, up 130.23% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 57000.0, down from 1308000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for XTNT reached as high as 9231000.0 in Q3 2023 and fell as low as 6204000.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 1251700.0 across 5 years, with a median of 1941000.0 in 2021.
- Across the five-year window, Income from Continuing Operations sank 7531.03% in 2022 and jumped 492.31% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 1265000.0 in 2021, then sank by 74.62% to 2209000.0 in 2022, then tumbled by 180.85% to 6204000.0 in 2023, then surged by 48.98% to 3165000.0 in 2024, then jumped by 101.8% to 57000.0 in 2025.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 57000.0 in Q4 2025, 1308000.0 in Q3 2025, and 3550000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | -3.17 Mn |
| Sep 30, 2024 | -5.02 Mn |
| Jun 30, 2024 | -3.86 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -6.20 Mn |
| Sep 30, 2023 | 9.23 Mn |
| Jun 30, 2023 | -2.19 Mn |
| Mar 31, 2023 | -2.08 Mn |
| Dec 31, 2022 | -2.21 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Jun 30, 2022 | -1.71 Mn |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -733,000.00 |
| Mar 31, 2021 | -29,000.00 |